Federal lawmakers expressed surprise at the lack of regulatory oversight over medical uses of radiation at hearings in the U.S. Congress today. While everyone in attendance agreed that the current regulatory environment needs fixing, the thorny question is how to go about doing it.
Congress surprised at lack of medical radiation oversight
Feb 25, 2010
Latest in Radiation Oncology/Therapy
Recalls stable for radiation oncology tools despite tech advancements
September 18, 2026
Minibeam radiotherapy performs well in first clinical trial
September 17, 2026
ASTRO issues first radiation therapy guideline for bladder cancer
September 16, 2026
ASTRO urges CMS to address radiation oncology shortfalls
September 14, 2026



















